Free Shipping on orders over $50

PRODUCT SUMMARY

Specialty Formula - Brain Support Softgels with Omega-3 Fish Oil (60 Count)

Availability: In stock
Stock Number :SCF-101-SG-060
  • Cognitive Support
  • Quick Notes:

    • May promote an elevated mood
    • May enhance mental alertness and physical energy
    • Promotes improved concentration

    View More Information
    pdfProduct Sheet PDF(920.43 KB )Download
    pdfFAQ PDF                   (821.74 KB )Download

    List Price: $52.52

    Price: $31.48

    Quantity:

    Product Information

    Quick Notes:

    • Scientifically formulated blend of synergistic vitamins, standardized extracts, and fish oil designed to support cognitive function!
    • Contains twelve (12) standardized and concentrated ingredients including Vitamin E, Vitamin B6, Folic Acid, Vitamin B12, Fish Oil (EPA & DHA), Ginkgo biloba, Phosphatidylserine, Rosemary extract, Ginger, and Inositol!
    • 100 mg of high quality SerinAid™ Phosphatidylserine, a trademark of ChemiNutra!
    • Molecularly distilled fish oil with high amount of DHA, an omega-3 fatty acid!
    • Contains Vitamin E for brain cell protection and 10 mg inositol for maintaining brain cell membrane!
    • Potent antioxidants protect against damage from free radicals!
    • Ginkgo extract standardized to 24% ginkgo flavonglycosides and 6% terpene lactones!
    • May improve circulation which has been shown to boost cognitive performance!
    • May enhance mental alertness and physical energy!
    • Promotes a healthy brain and supports memory!
    • Offers neuro-protection!
    • Supports circulation!
    • Convenient, easy-to-swallow softgel!
       

    Overview:

    Brain Support is a unique combination of key herbs and vitamins that support overall health and optimal mental wellness. As we age, memory lapses can become routine and are commonly attributed to “advancing years”. However, age-related cognitive decline is not the only factor involved in incidents of forgetfulness. Possible causes for cognitive decline can include sedative medications and depression which can affect concentration.

    Aging may be unavoidable, but the side effects may be prevented or lessened through a healthy diet and lifestyle. Key nutrients have been extensively researched to ease the aging process. Our formula has been designed to combat the effects of age-related cognitive decline, promote healthy circulation, and promote mental clarity.

    Our formula contains ginkgo biloba and rosemary which are known to help promote healthy circulation to the brain. We also added B-vitamins to help support homocysteine levels already within a normal range. Phosphatidylserine and phosphatidylcholine both maintain the cell membrane surrounding brain cells, thereby helping to ensure proper cell signaling between neurons. Omega-3 fish oils used to thin the blood and improve circulation also may assist healthy brain function. DHA, a fatty acid derived from omega-3 fish oil, is rapidly taken up by brain cells.
     

    Research Indicates:

    • May promote an elevated mood
    • May enhance mental alertness and physical energy
    • Promotes improved concentration
    • Studies indicate Gingko Biloba improves brain circulation which may lead to enhanced memory
    • May improve delivery of nutrients to the brain
    • May reduce leg pain arising from intermittent claudication and similar disorders
    • May improve symptoms associated with diabetes and various circulatory conditions
    • May delay the onset of Alzheimer’s disease
    • Helps rid the body of free radicals due to its antioxidant properties

    Ingredients

    D-alpha tocopherol succinate

    DHA

    Docosahexaenoic Acid

    Eicosapentaenoic Acid

    EPA

    Fish Oil

    Flavone glycosides

    Folic Acid or Vitamin B9

    Ginkgo Biloba Extract (leaf)

    Inositol

    Phosphatidylserine

    Pyridoxine

    Rosemary Extract

    Rosmarinus officinal

    SerinAid

    Terpene Lactones

    vitamin b12 or cyanocobalamin

    Vitamin B6

    Vitamin E

    Suggested Use: Take two softgels daily with meals.

    Storage:

    Keep in a cool, dry place.

    Allergy Warnings:

    This product is contraindicated for individuals with hypersensitivity to any of its ingredients.

    Interactions:

    • Everyone has unique body chemistry. All patients should be aware of potential drug and supplement interaction. You are encouraged to consult with your primary health care professional before taking any supplement product.

    • This product contains multiple ingredients. Please refer to the individual vitamin or mineral product page for interaction information. Always consult with your primary care professional before taking any supplement product.

    • If you are taking anticoagulant medications, have a clotting or bleeding disorder, or are pregnant or lactating, consult a health care practitioner prior to using this product.

    • Autonomic changes may include a slight increase in body temperature and respiratory rate. If these symptoms do not subside, discontinue use, and consult your health practitioner.

    • If you have any type of cardiovascular disease, consult your health care practitioner before taking Brain Boost.

    • In some cases, Brain Boost may affect the dose and activity of the other medications you are taking for health conditions such as cardiovascular disease.

    Pregnancy Warning:

    If you are pregnant, nursing, have any health condition, or are taking any medications please consult with your health care practitioner before using this product.

    Keep out of reach of children.

    Disclaimer:

    • The following scientific literature references, articles, and statements have not been evaluated by the Food and Drug Administration (FDA).
    • This product is not intended to treat, cure or prevent any disease.
    • Information about this product is intended for your general knowledge only and is not a substitute for professional medical advice or treatment.
    THANKS!

    Ginkgo Biloba:



    1. van Dongen MC, van Rossum E, Kessels AG, et al. The efficacy of ginkgo for elderly people with dementia and age-associated memory impairment: new results of a randomized clinical trial. J Am Geriatr Soc. 2000;48:1183-1194.

    2. Winther K, Randlov C, Rein E, et al. Effects of Ginkgo biloba extract on cognitive function and blood pressure in elderly subjects. Curr Ther Res. 1998;59:881-888.

    3. van Dongen MC, van Rossum E, Kessels AG, et al. The efficacy of ginkgo for elderly people with dementia and age-associated memory impairment: new results of a randomized clinical trial. J Am Geriatr Soc. 2000;48:1183-1194.

    4. Le Bars PL, Katz MM, Berman N, et al. A placebo-controlled, double-blind, randomized trial of an extract of Ginkgo biloba for dementia. North American EGb Study Group. JAMA. 1997;278:1327-1332.

    5. Rigney U, Kimber S, Hindmarch I. The effects of acute doses of standardized Ginkgobiloba extract on memory and psychomotor performance in volunteers. Phytotherapy Res. 1999;13:408-415.

    6 Lovera J, Bagert B, Smoot K, et al. Ginkgo biloba for the improvement of cognitive performance in multiple sclerosis: a randomized, placebo-controlled trial. Mult Scler. 2007;13:376-385.

    7. McCarney R, Fisher P, Iliffe S, et al. Ginkgo biloba for mild to moderate dementia in a community setting: a pragmatic, randomised, parallel-group, double-blind, placebo-controlled trial. Int J Geriatr Psychiatry. 2008 Jun 9.

    8. Weinmann S, Roll S, Schwarzbach C, Vauth C, Willich SN.Effects of Ginkgo biloba in dementia: systematic review and meta-analysis. BMC Geriatr. 2010;10:14.


    Fish Oil (EPA and DHA):



    1. Kwak SM, Myung SK, Lee YJ, Seo HG. Efficacy of omega-3 fatty acid supplements (eicosapentaenoic acid and docosahexaenoic acid) in the secondary prevention of cardiovascular disease: a meta-analysis of randomized, double-blind, placebo-controlled trials. Arch Intern Med. 2012 Apr 9.

    2. Lungershausen YK, Abbey M, Nestel PJ, et al. Reduction of blood pressure and plasma triglycerides by omega-3 fatty acids in treated hypertensives. J Hypertens. 1994;12:1041-1045.

    3. von Schacky C, Angerer P, Kothny W, et al. The effect of dietary omega-3 fatty acids on coronary atherosclerosis. A randomized, double-blind, placebo-controlled trial. Ann Intern Med. 1999;130:554-562.

    4. Mori TA, Bao DQ, Burke V, et al. Docosahexaenoic acid but not eicosapentaenoic acid lowers ambulatory blood pressure and heart rate in humans. Hypertension. 1999;34:253-260.

    5. Ascherio A, Rimm EB, Stampfer MJ, et al. Dietary intake of marine n-3 fatty acids, fish intake, and the risk of coronary disease among men. N Engl J Med. 1995;332:977-982.

    6. Peet M, Brind J, Ramchand CN, et al. Two double-blind placebo-controlled pilot studies of eicosapentaenoic acid in the treatment of schizophrenia. Schizophr Res. 2001;49:243-251.

    7. Gerbi A, Maixent JM, Ansaldi JL, et al. Fish oil supplementation prevents diabetes-induced nerve conduction velocity and neuroanatomical changes in rats. J Nutr. 1999;129:207-213.

    8. Almallah YZ, El-Tahir A, Heys SD, et al. Distal procto-colitis and n-3 polyunsaturated fatty acids: the mechanism(s) of natural cytotoxicity inhibition. Eur J Clin Invest. 2000;30:58-65.

    9. Conquer JA, Martin JB, Tummon I, et al. Effect of DHA supplementation on DHA status and sperm motility in asthenozoospermic males. Lipids. 2000;35:149-154.

    10. Bassey EJ, Littlewood JJ, Rothwell MC, et al. Lack of effect of supplementation with essential fatty acids on bone mineral density in healthy pre- and postmenopausal women: two randomized controlled trials of Efacal v. calcium alone. Br J Nutr. 2000;83:629-635.

    11. Richardson AJ, Puri BK. A randomized double-blind, placebo-controlled study of the effects of supplementation with highly unsaturated fatty acids on ADHD-related symptoms in children with specific learning difficulties. Prog Neuropsychopharmacol Biol Psychiatry.
    2002;26:233-239.

    12. Voigt RG, Llorente AM, Jensen CL, et al. A randomized, double-blind, placebo-controlled trial of docosahexaenoic acid supplementation in children with attention-deficit/hyperactivity disorder. J Pediatr. 2001;139:189-196.

    13. Nenseter MS, Osterud B, Larsen T, et al. Effect of Norwegian fish powder on risk factors for coronary heart disease among hypercholesterolemic individuals. Nutr Metab Cardiovasc Dis. 2000;10:323-330.

    14. van Dam M, Stalenhoef AF, Wittekoek J, et al. Efficacy of concentrated n-3 fatty acids in hypertriglyceridaemia: a comparison with gemfibrozil. Clin Drug Invest. 2001;21:175-181.

    15. Montori VM, Farmer A, Wollan PC, et al. Fish oil supplementation in type 2 diabetes: a quantitative systematic review. Diabetes Care. 2000;23:1407-1415.

    16. Volker D, Fitzgerald P, Major G, et al. Efficacy of fish oil concentrate in the treatment of rheumatoid arthritis. J Rheumatol. 2000;27:2343-2346.

    17. Montori VM, Farmer A, Wollan PC, et al. Fish oil supplementation in type 2 diabetes: a quantitative systematic review. Diabetes Care. 2000;23:1407-1415.

    18. Yam D, et. al. The effect of omega-3 fatty acids on risk factors for cardiovascular diseases. Harefuah. 2001;140:1156-1158.

    19. Bucher HC, Hengstler P, Schindler C, et al. N-3 polyunsaturated fatty acids in coronary heart disease: a meta-analysis of randomized controlled trials. Am J Med. 2002;112:298-304.

    20. Schmitz PG, McCloud LK, Reikes ST, et al. Prophylaxis of hemodialysis graft thrombosis with fish oil: double-blind, randomized, prospective trial. J Am Soc Nephrol. 2002;13:184-190.

    21. Nemets B, Stahl Z, Belmaker RH. Addition of omega-3 fatty acid to maintenance medication treatment for recurrent unipolar depressive disorder. Am J Psychiatry. 2002;159:477-479.

    22. Mori TA, Burke V, Puddey IB, et al. Purified eicosapentaenoic and docosahexaenoic acids have differential effects on serum lipids and lipoproteins, LDL particle size, glucose, and insulin in mildly hyperlipidemic men. Am J Clin Nutr. 2000;71:1085-1094.

    23. Geleijnse JM, Giltay EJ, Grobbee DE, et al. Blood pressure response to fish oil supplementation: metaregression analysis of randomized trials. J Hypertens. 2002;20:1493-1499.

    24. Peet M, Horrobin DF. A dose-ranging study of the effects of ethyl-eicosapentaenoate in patients with ongoing depression despite apparently adequate treatment with standard drugs. Arch Gen Psychiatry. 2002;59:913-919.

    25. Fenton WS, Dickerson F, Boronow J, et al. A placebo-controlled trial of omega-3 fatty acid (ethyl eicosapentaenoic acid) supplementation for residual symptoms and cognitive impairment in schizophrenia. Am J Psychiatry. 2001;158:2071-2074.

    26. Harel Z, Gascon G, Riggs S, et al. Supplementation with omega-3 polyunsaturated fatty acids in the management of recurrent migraines in adolescents. J Adolesc Health. 2002;31:154-161.

    27. Woodman RJ, Mori TA, Burke V, et al. Effects of purified eicosapentaenoic acid and docosahexaenoic acid on platelet, fibrinolytic and vascular function in hypertensive type 2 diabetic patients. Atherosclerosis. 2003;166:85-93.

    28. Mangoni AA, Sherwood RA, Swift CG, et al. Folic acid enhances endothelial function and reduces blood pressure in smokers: a randomized controlled trial. J Intern Med. 2002;252:497-503.

    29. Cleland L, James M, Proudman S. The role of fish oils in the treatment of rheumatoid arthritis. Drugs. 2003;63:845-853.

    30. Zanarini MC, Frankenburg FR. Omega-3 Fatty Acid treatment of women with borderline personality disorder: a double-blind, placebo-controlled pilot study. Am J Psychiatry. 2003;160:167-169.

    31. Blommers J, De Lange-De Klerk ES, Kuik DJ, et al. Evening primrose oil and fish oil for severe chronic mastalgia: A randomized, double-blind, controlled trial. Am J Obstet Gynecol. 2002;187:1389-1394.

    32. Adam O, Beringer C, Kless T, et al. Anti-inflammatory effects of a low arachidonic acid diet and fish oil in patients with rheumatoid arthritis. Rheumatol Int. 2003;23:27-36.

    33. Marangell LB, Martinez JM, Zboyan HA, et al. A double-blind, placebo-controlled study of the omega-3 fatty acid docosahexaenoic acid in the treatment of major depression. Am J Psychiatry. 2003;160:996-998.

    34. Khan F, Elherik K, Bolton-Smith C, et al. The effects of dietary fatty acid supplementation on endothelial function and vascular tone in healthy subjects. Cardiovasc Res. 2003;59:955-962.

    35. Grundt H, Nilsen DW, Mansoor MA, et al. Reduction in homocysteine by n-3 polyunsaturated fatty acids after 1 year in a randomised double-blind study following an acute myocardial infarction: no effect on endothelial adhesion properties. Pathophysiol Haemost Thromb.
    2003;33:88-95.

    36. Stevens L, Zhang W, Peck L, et al. EFA supplementation in children with inattention, hyperactivity, and other disruptive behaviors. Lipids. 2003;38:1007-1021.

    37. Liu M, Wallmon A, Wallin R, et al. Effects of stable fish oil and simvastatin on plasma lipoproteins in patients with hyperlipidemia. Nutr Res. 2003;23:1027-1034.

    38. Frangou S, Lewis M, McCrone P, et al. Efficacy of ethyl-eicosapentaenoic acid in bipolar depression: randomised double-blind placebo-controlled study. Br J Psychiatry. 2006;188:46-50.

    39. Itomura M, Hamazaki K, Sawazaki S, et al. The effect of fish oil on physical aggression in schoolchildren - a randomized, double-blind, placebo-controlled trial. J Nutr Biochem. 2005;16:163-171.

    40. Richardson AJ, Montgomery P. The Oxford-Durham Study: A Randomized, Controlled Trial of Dietary Supplementation With Fatty Acids in Children With Developmental Coordination Disorder. Pediatrics. 2005;115:1360-1366.

    41. Schwellenbach LJ, Olson KL, McConnell KJ, et al. The triglyceride-lowering effects of a modest dose of docosahexaenoic acid alone versus in combination with low-dose eicosapentaenoic acid in patients with coronary artery disease and elevated triglycerides. J Am Coll Nutr. 2006;25:480-485.

    42. McKenney JM, Sica D. Prescription omega-3 fatty acids for the treatment of hypertriglyceridemia. Am J Health Syst Pharm. 2007;64:595-605.

    43. Theobald HE, Goodall AH, Sattar N, et al. Low-dose docosahexaenoic acid lowers diastolic blood pressure in middle-aged men and women. J Nutr. 2007;137:973-978.

    44. Yokoyama M, Origasa H, Matsuzaki M, et al. Effects of eicosapentaenoic acid on major coronary events in hypercholesterolaemic patients (JELIS): a randomised open-label, blinded endpoint analysis. Lancet. 2007;369:1090-1098.

    45. Lin PY, Su KP. A meta-analytic review of double-blind, placebo-controlled trials of antidepressant efficacy of omega-3 fatty acids. J Clin Psychiatry. 2007;68:1056-1061.

    46. Spadaro L, Magliocco O, Spampinato D, et al. Effects of n-3 polyunsaturated fatty acids in subjects with nonalcoholic fatty liver disease. Dig Liver Dis. 2007 Dec 2.

    47. Chong EW, Kreis AJ, Wong TY, et al. Dietary omega-3 fatty acid and fish intake in the primary prevention of age-related macular degeneration: a systematic review and meta-analysis. Arch Ophthalmol. 2008;126:826-833.

    48. van de Rest O, Geleijnse JM, Kok FJ, et al. Effect of fish-oil supplementation on mental well-being in older subjects: a randomized, double-blind, placebo-controlled trial. Am J Clin Nutr. 2008;88:706-713.

    49. Eslick GD, Howe PR, Smith C, et al. Benefits of fish oil supplementation in hyperlipidemia: a systematic review and meta-analysis. Int J Cardiol. 2008 Sep 5.

    50. Emsley R, Niehaus DJ, Oosthuizen PP, et al. Safety of the omega-3 fatty acid, eicosapentaenoic acid (EPA) in psychiatric patients: Results from a randomized, placebo-controlled trial. Psychiatry Res. 2008;161:284-291.

    51. Zhu FS, Liu S, Chen XM, et al. Effects of n-3 polyunsaturated fatty acids from seal oils on nonalcoholic fatty liver disease associated with hyperlipidemia. World J Gastroenterol. 2008;14:6395-6400.

    52. Schubert R, Kitz R, Beermann C, et al. Effect of n-3 polyunsaturated fatty acids in asthma after low-dose allergen challenge. Int Arch Allergy Immunol. 2008 Nov 11.

    53. León H, Shibata MC, Sivakumaran S, Dorgan M, Chatterley T, Tsuyuki RT. Effect of fish oil on arrhythmias and mortality: systematic review. BMJ. 2008 Dec 23;337:a2931.

    54. Doornbos B, van Goor SA, Dijck-Brouwer DA, Schaafsma A, Korf J, Muskiet FA. Supplementation of a low dose of DHA or DHA+AA does not prevent peripartum depressive symptoms in a small population based sample. Prog Neuropsychopharmacol Biol Psychiatry. 2009;33:49-52.

    55. Zhao YT, Chen Q, Sun YX, Li XB, Zhang P, Xu Y, Guo JH. Prevention of sudden cardiac death with omega-3 fatty acids in patients with coronary heart disease: a meta-analysis of randomized controlled trials. Ann Med. 2009;41:301-10.

    56. Hartweg J, Farmer AJ, Holman RR, Neil A. Potential impact of omega-3 treatment on cardiovascular disease in type 2 diabetes. Curr Opin Lipidol. 2009;20:30-8.

    57. Amminger GP, Schäfer MR, Papageorgiou K, et al. Long-chain omega-3 fatty acids for indicated prevention of psychotic disorders: a randomized, placebo-controlled trial. Arch Gen Psychiatry. 2010 Feb;67(2):146.

    58. Makrides M, Gibson RA, McPhee AJ, et al. Effect of DHA supplementation during pregnancy on maternal depression and neurodevelopment of young children: a randomized controlled trial. JAMA. 2010;304(15):1675-1683.

    59. Kowey PR, Reiffel JA, Ellenbogen KA, Naccarelli GV, Pratt CM. Efficacy and safety of prescription omega-3 fatty acids for the prevention of recurrent symptomatic atrial fibrillation: a randomized controlled trial. JAMA. 2010;304(21):2363-2372. Epub 2010 Nov 15.

    60. Nodari S, Triggiani M, Campia U, et al. Effects of n-3 polyunsaturated fatty acids on left ventricular function and functional capacity in patients with dilated cardiomyopathy. J Am Coll Cardiol. 2011;57(7):870-879.

    61. Bloch MH, Qawasmi A. Omega-3 fatty acid supplementation for the treatment of children with attention-deficit/hyperactivity disorder symptomatology: systematic review and meta-analysis. J Am Acad Child Adolesc Psychiatry. 2011;50(10):991-1000.

    62. Sarris J, Mischoulon D, Schweitzer I. Omega-3 for bipolar disorder: meta-analyses of use in mania and bipolar depression. J Clin Psychiatry. 2011 Aug 9.

    63. Liu T, Korantzopoulos P, Shehata M, Li G, Wang X, Kaul S. Prevention of atrial fibrillation with omega-3 fatty acids: a meta-analysis of randomised clinical trials. Heart. 2011;97(13):1034-1040.

    FAQ

    Frequently Asked Questions - Specialty Products

    • What is Phase 2™ Starch Neutralizer?

      Phase 2™ is an amazing, non-stimulant, all-natural nutritional ingredient that is derived from the white kidney bean. It is the first nutritional ingredient that has been clinically and scientifically proven to neutralize starch, which is found in common foods such as potatoes, breads, pasta, rice, corn and crackers.

       

      Phase 2™ is a safe yet powerful nutritional ingredient, clinically studied for its role in reducing the absorption of starch calories. Phase 2™ helps you to enjoy those foods that you love and to participate in special meals containing quantities of starches in excess of your nutritional goals.

    • What role do starchy foods play in weight management?

      During the digestive process, your body converts carbohydrates found in starchy foods (such as potatoes and pasta) into sugars. It digests these starchy carbohydrates with alpha amylase, an enzyme that is produced by the pancreas.

       

      These sugar calories are then used by the body for fuel, with the excess sugar stored for future use, often as fat. Unfortunately, an imbalance between calories eaten and calories burned means that these stored fat supplies can accumulate in the body.

       

    • How does Phase 2® in Calorie Quencher® block starch from being absorbed in the body?

      Phase 2® has been shown to bind with the starch digestion enzyme alpha amylase, neutralizing starch calories and preventing them from turning into glucose (sugar) in the body.

       

    • When should I take Phase 2™?

      Recent research has shown the most optimum time to take Phase 2™ is just before a starch-rich meal, along with 8 oz. of water. However, the studies also showed that Phase 2™ could still provide some of its starch "neutralizing" benefits when taken during, or just after, a starchy meal. One study showed that Phase 2™ is also effective if the capsules are opened and the contents sprinkled right onto food.

       

    • Do we lose nutrients from foods when we take Calorie Quencher®?

      The LipoSan Ultra® in this product is a fat binder so it reduces the amount of fat transported from the small intestine into the blood stream; therefore fat soluble vitamins (A, D, E, K) in foods could have reduced transport from the small intestine into the blood due to less fat to accompany them. This would be true for fat soluble nutrients coming from supplements as well, so it is best to take multi-vitamins separate from Calorie Quencher. The risk of a nutrient deficiency occurring from Calorie Quencher is negligible if the overall diet is plentiful in nutrients and the product is taken as recommended

       

    • Does Phase 2™ cause any toxic side effects?

      A dose equivalent to 74 grams taken daily for 90 days by a 165 lb. person showed no signs of toxicity. Pharmachem Laboratories Inc., announced that a Chronic Toxicity Study (L.D. 50) demonstrated that Phase 2™ Starch Neutralizer™, the first standardized white bean extract used in a variety of healthy weight management supplements, is safe and non-toxic.

       

      “Phase 2™ showed no signs of chronic toxicity at doses up to 1.0 gm per kg of body weight for up to 90 days,” said Ramadasan Kuttan, Ph.D., director, Amala Cancer Research Center, Thrissur, India, who conducted the study along with R. C. Srimal, M.D. “The data indicates that administration of Phase 2™ for 90 days did not produce any adverse reaction…” (as determined from a number of different measurements, such as organ weight, necropsy, hematological and biochemical values).

       

    • Does Calorie Quencher® have any side effects?

      Studies show that the side effects of these non-stimulatory ingredients are minimal and most often limited to problems such as gastric irritation, which is often due to taking too high of a dosage. We add fennel seed to our product to minimize gastric irritation naturally.

       

      It is important to note that fat and carbohydrate binding products like Calorie Quencher® should only be taken with meals that are high in carbohydrates and fat and should not be taken with more than two meals per day. It is suggested that multiple vitamins and other dietary supplements be taken at separate meals to decrease the risk of a vitamin and/or mineral deficiency while consuming these types of diet helpers. It should also be stressed that in order to achieve long lasting weight loss, in addition to supplementation, one must improve daily dietary and lifestyle factors.

    • Are there any human studies that prove Phase 2 ™ effectiveness?

      Yes. Human studies indicate that this natural compound has the ability to inhibit starches found in foods from being broken down to simple sugar. This amylase-inhibiting effect causes most starches to pass through the GI tract undigested, thus causing a smaller increase in blood glucose levels within 15 to 80 minutes following the intake of starchy foods. The following describes one of the studies performed on Phase 2.

    • How many grams of fat will be absorbed by a serving size of Chitosan?

      As with many dietary supplements, different people will experience different results depending on a number of factors, including body type, metabolism, and diet. We use the Liposan Ultra brand of Chitosan because studies show that Liposan Ultra binds several times more dietary fat than other leading chitosan brands. In vitro, Liposan Ultra was shown to absorb up to 88 grams of fat, but this doesn't mean it will necessarily have the same effect when ingested by humans. Studies are ongoing.

    • Can I take Chitosan with prescription medications or other supplements, and are there any side effects?

      Since Chitosan binds to fat in the stomach, it is advisable to take it 3-4 hours prior to the ingestion of fat soluble medications or nutrients. If Chitosan is used simultaneously with certain medications, it may block the desired effects of that medication.

      Check with your doctor before mixing Chitosan with prescription medications. If you have questions about taking Chitosan with dietary supplements, check with a certified nutritionist or your local health food store. There are no known side effects associated with Chitosan supplementation.

    • How does Policosanol support heart and cardiovascular health?

      Policosanol can help maintain healthy cholesterol levels by decreasing cholesterol production in the liver and increasing the breakdown of LDL (low-density lipoprotein or “bad”) cholesterol. It also decreases the stickiness of particles in the blood known as platelets, which might help reduce blood clots.

       

    • What is the alcohol breakdown of Policosanol and where is it sourced?

      Our policosanol contains at least 50% octacosanol, a derivative of sugar cane wax grown in the Suzhoo province of China. It also contains eight other high primary aliphatic alcohols that are included in policosanol as follows:

      - Triacontanol .15-30%
      - Hexacosanol .10-20%
      - Dotriacontanol.0.5-5%
      - Tetracosanol .0.5-5%
      - Heptacosanol.<5%
      - Nonacosanol.<5%
      - Hentriacontanol.<2%

    • How is Policosanol effective without lowering levels of CoQ10?

      The main problem with many cholesterol drugs is that when taken over a long period of time, they begin to lower levels of the important co-enzyme CoQ10. Policosanol has a similar mechanism of action to these drugs without lowering CoQ10 levels.

      Many drugs inhibit the expression of the enzyme HMG-CoA reductase, which is a catalyst in the production of mevalonic acid. Mevalonic acid is then processed by the liver and transformed into cholesterol. So, it would reason, the less HMG-CoA reductase in one’s system, the less mevalonic acid and, hence, less cholesterol. But it is not so simple. HMG-CoA reductase should not be completely eliminated in order to lower cholesterol. Low levels are beneficial to a point, and then can become counterproductive.

      HMG-CoA reductase is also used in the formation of farnesyl diphosphate or FPP.FPP, though used in squalene, another cholesterol precursor, is also used in production of CoQ10.Not enough FPP, and not enough CoQ10 will be produced. This is why some drugs which inhibit HMG-CoA reductase expression have the nasty side effect of lowered CoQ10 levels. Policosanol, on the other hand, inhibits expression by only about 50%, which is not enough to significantly affect production of FPP

    • What are plant sterols?

      Plant sterols (also called phytosterols) are plant lipids present in fruits, vegetables, grains and nuts. Structurally, they are similar to cholesterol except at one position on the sterol side chain. It is thought that phytosterols reduce cholesterol by displacing cholesterol from micelles in the body, thus inhibiting cholesterol absorption.

    • How do Corowise™ plant sterols in Cholesterol Complex impact cholesterol?

      In terms of their molecular structure, plant sterols “look” a lot like cholesterol. When taken before a meal these plant sterols compete with cholesterol during digestion so the body absorbs less dietary cholesterol. The overall effect in clinical studies on Corowise™ has been an average LDL (“bad”) reduction of 8 – 15% with no known adverse side effects.

       

    • What is the breakdown of sterols in the plant sterols in Cholesterol Complex?

      Roughly 40-58% of the sterols consist of sitosterol, 20-28% as camposterol, and 14-23% as stigmasterol

    • Do I need to take another multi, if I’m taking Hair, Skin & Nails Multi?

      Our Hair, Skin & Nails Multi is based on our best-selling Basic Multi® which is a great foundation for nutrition needs. However, in addition to basic nutrients, our Hair, Skin & Nails Multi has added specialty antioxidants for skin and overall cellular health. It also contains silica, MSM and amino acids for collagen support. Collagen is responsible for skin’s resiliency and elasticity, but its production slows as we age.

    • Are your Melatonin products natural or synthetic?

      We use synthetic sources of melatonin. According to the 2001 Physician’s Desk Reference for Nutritional Supplements, “melatonin supplements derived from animals [i.e. natural] should be avoided.”

    • What is Bio-Shield Technology™?

      The Bio-Shield Technology™ process not only delivers nutrients exactly where they need to go over a sustained period of time, but also enhances the absorption of the bioactives. Technically speaking, the Bio-Shield Technology™ process is a natural coating that is used to facilitate the absorption of the intact bioavailable anthocyanins and proanthocyanins. This all-natural matrix protects these active ingredients of the fruit by delivering them past the stomach acids and prolonging their stability. Because the Bio-Shield Technology™ product is derived totally from a natural fruit base, it is able to limit the rate of acid degradation of the bioactives while simultaneously assisting with their absorption.

    • What is the source of your lutein?

      Lutein used in all of our products is derived from marigold flowers — they are a source naturally high in lutein

    • What is Lutein?

      Lutein and Zeaxanthin are the only two carotenoids concentrated in the macula of the human eye. The macula is a collection of cells in the back of the eye that convert light into signals the brain can understand. Clinical and animal data indicate that these carotenoids could protect the macula from oxidative or light damage. Epidemiological data has shown that high levels of dietary Lutein and Zeaxanthin intake have been associated with a reduced risk of Age-Related Macular Degeneration (the number one cause of blindness in North America).

    • What are carotenoids?

      Carotenoids are a family of phytochemical compounds found in fruits, vegetables and leafy green plants. They provide the bright yellow, orange and red pigments to the fruits and vegetables we eat. Of more than 600 known carotenoids in nature, only about 20 are found in human plasma and tissues. The principal carotenoids found in humans are alpha-carotene, beta-carotene, beta-cryptoxanthin, lutein, lycopene and zeaxanthin. Researchers are currently studying the many health benefits of these compounds

    • What do lutein and zeaxanthin do?

      The carotenoids, lutein and zeaxanthin, concentrate in the macular area of the eye and can protect against oxidative stress.

       

    • If zeaxanthin makes up a large part of the macula, why is it not included in all of your products?

      Though zeaxanthin is a large part of the macula, it is not necessary to consume large amounts of it so long as you consume enough lutein. Our lutein product does contain a small amount of zeaxanthin, but since lutein can be processed into zeaxanthin after consumption, that ingredient has been omitted from the other two products. Most people do not suffer from a zeaxanthin deficiency, but sufficient lutein intake is crucial to maintaining proper levels.

    • How much spinach would I have to eat to get 6 mg of lutein?

      About 2 cups of raw spinach would supply 6 mg of lutein.

    • What is the source of lutein in Ocu Complete® with Lutein?

      The lutein in Ocu Complete® with Lutein comes from marigold flowers.

    • In Ocu Complete® with Lutein, how many milligrams of lutein does 10,000 mcg equal?

      There is 10 mg of lutein in 10,000 mcg.

    • Why is your Lutein softgel expensive?

      Lutein used in our products containing FloraGLO® and LuteMax™ 2020 are in the ester-free form. Ester-free may be better absorbed and utilized by the body compared with other brands’ ester form which requires an additional step by the body to break it down and deliver it to necessary tissue. In the human eye lutein is present in the free form. In marigold flowers it is present in the ester form. If you give the body lutein in free form, it gets deposited to the macula of the eye. If you consume lutein in the ester form the body hydrolyzes (or de-esterifies) it, removing the fatty acid attached to the lutein, and then delivers the free form to the eye. Thus, it is easier to give the body the form of lutein it uses. Lutein esters may offer benefit, but it requires the body do more work since it has to convert the ester form to the ester-free form.

    • How much caffeine is in a serving of Green Coffee Bean?

      Very little. There is less than 20 mg of caffeine per capsule. By comparison, a cup of coffee contains 95 mg.

    Congratulations, your item has been added to the shopping cart!

    Continue Shopping (or) Checkout
    visamastercarddiscover